Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 16/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | PPARA | Q07869 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 1/20 | 0.35 |
| ▸ | F2 | P00734 | 2/20 | 0.34 |
| ▸ | TMPRSS6 | Q8IU80 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6491914 | 0.88 | F2 (0.45) | GHSRPPARACTSSF2TMPRSS6 | |
| SCHEMBL6480782 | 0.87 | GHSR (0.46) | GHSR | |
| SCHEMBL6490939 | 0.85 | ALDH1A1 (0.32) | GHSRPPARGPPARACTSSF2 | |
| SCHEMBL6491275 | 0.83 | GHSR (0.37) | GHSRPPARGPPARACTSSF2 | |
| SCHEMBL6480351 | 0.83 | CA2 (0.32) | — | |
| SCHEMBL6493735 | 0.81 | SCN1A (0.35) | GHSR | |
| SCHEMBL6481377 | 0.80 | FOLH1 (0.30) | — | |
| SCHEMBL6481410 | 0.80 | PPARA (0.34) | GHSRPPARGPPARACTSS | |
| SCHEMBL6480136 | 0.80 | S1PR1 (0.36) | GHSRPPARGPPARACTSS | |
| SCHEMBL6488832 | 0.78 | MMP9 (0.43) | GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050261332-A1 | Sulfonamides and uses thereof | ELIXIR PHARMACEUTICALS, INC. | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261332-A1 | Sulfonamides and uses thereof | GLS2, STS, ABAT | GHSR 3083/4885PPARG 247/4885PPARA 174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.